Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Maintenance Renal Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00149864
What this trial is testing

Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A302

Who this might be right for
Renal Transplant
Novartis 264
Not applicableStudy completedNCT01936519
What this trial is testing

Conversion to Everolimus From Calcineurin Inhibitor With Mycophenolic Acid: Impact on Long Term Renal Function in Liver Transplantation.

Who this might be right for
ImmunosuppressionRenal Failure
Milton S. Hershey Medical Center 24
Post-approval studies (Phase 4)Study completedNCT00502242
What this trial is testing

Study Evaluating The Effect Of Ramipril On Urinary Protein Excretion In Renal Transplant Patients Converted To Sirolimus

Who this might be right for
Kidney Transplant
Pfizer 229
Testing effectiveness (Phase 2)Ended earlyNCT00472082
What this trial is testing

Early Conversion From Tacrolimus to Efalizumab Maintenance Therapy in Kidney Transplant Recipients

Who this might be right for
Kidney TransplantationChronic Kidney Failure
Emory University 5
Large-scale testing (Phase 3)WithdrawnNCT03596970
What this trial is testing

Study of the Effect of Everolimus Immunosuppressive Combination Therapies on Renal Function When Used as a Maintenance Treatment for Liver Transplant Patients.

Who this might be right for
Liver Transplantation
Novartis Pharmaceuticals
Not applicableLooking for participantsNCT07231770
What this trial is testing

Sulfamethoxazole Prophylaxis Duration After Renal Transplantation

Who this might be right for
FeverChest Tightness
Anhui Provincial Hospital 450
Post-approval studies (Phase 4)Ended earlyNCT00434590
What this trial is testing

Efficacy and Tolerability of Full Dose Enteric-coated Mycophenolate Sodium, in Addition to Cyclosporine for Microemulsion Reduced Dose, in Maintenance Renal Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 10
Post-approval studies (Phase 4)Study completedNCT01172418
What this trial is testing

Randomized Trial of 2 Antibody Induction Steroid Avoidance Protocols

Who this might be right for
Transplant; Failure, Kidney
University of Miami 200
Post-approval studies (Phase 4)Study completedNCT00284947
What this trial is testing

Safety and Efficacy of Basiliximab in Calcineurin Inhibitor Intolerant Long-term Kidney Transplant Recipients Treated With Mycophenolic Acid and Steroids

Who this might be right for
Kidney TransplantationAdverse Effects
Novartis 7
Post-approval studies (Phase 4)Study completedNCT00118742
What this trial is testing

Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Who this might be right for
Liver Transplantation
Hoffmann-La Roche 293
Post-approval studies (Phase 4)WithdrawnNCT01269684
What this trial is testing

Immediate Conversion From Tacrolimus to Everolimus in Stable Maintenance Renal Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals
Post-approval studies (Phase 4)Active Not RecruitingNCT05193565
What this trial is testing

Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant Patients

Who this might be right for
Kidney Transplantation
Chong Kun Dang Pharmaceutical 206
Post-approval studies (Phase 4)WithdrawnNCT02062892
What this trial is testing

Differentiating Everolimus Versus Sirolimus in Combination With Calcineurin Inhibitors in Kidney Transplant Patients

Who this might be right for
Kidney Transplantation
University of Colorado, Denver
Large-scale testing (Phase 3)Study completedNCT01820572
What this trial is testing

A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based

Who this might be right for
Kidney Transplantation
Bristol-Myers Squibb 446
Post-approval studies (Phase 4)Study completedNCT01169701
What this trial is testing

24 Months Follow-up, Two Arm Study to Compare the Cardiovascular Profile in a Regimen With Everolimus + Mycophenolic Acid (MPA) Versus (vs.) a Regimen of CNI+MPA in Maintenance Renal Transplant Recipients

Who this might be right for
Renal Transplant
Novartis Pharmaceuticals 71
Not applicableUnknownNCT06013358
What this trial is testing

DdcfDNA in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
Seoul National University Hospital 200
Post-approval studies (Phase 4)Study completedNCT00905515
What this trial is testing

Optima: Optimizing Prograf Therapy in Maintenance Allografts II

Who this might be right for
Kidney Transplantation
East Carolina University 63
Post-approval studies (Phase 4)UnknownNCT04224350
What this trial is testing

Study to Evaluate the Efficacy and Safety of Tacrolimus in Kidney Transplant Recipients (BLOSSOM)

Who this might be right for
Kidney Transplant
Chong Kun Dang Pharmaceutical 184
Not applicableLooking for participantsNCT06829719
What this trial is testing

TTV-based mAnagement Of Long-term ImmunosuppreSsion in Kidney Transplantation

Who this might be right for
InfectionCancerRejection+1 more
Hospices Civils de Lyon 600
Post-approval studies (Phase 4)Study completedNCT00807144
What this trial is testing

Standard Versus Prolonged-release Tacrolimus Monotherapy After Alemtuzumab Induction in Kidney Transplantation

Who this might be right for
End-stage Renal FailureGraft Rejection
Imperial College Healthcare NHS Trust 102
Next Page